InvestorsHub Logo
Followers 7
Posts 496
Boards Moderated 0
Alias Born 11/15/2012

Re: Xrouter post# 26543

Saturday, 11/29/2014 10:20:02 AM

Saturday, November 29, 2014 10:20:02 AM

Post# of 48316
Notwithstanding Dr. Pierce's relationship with Merck, I found the hiring of one of their senior legal personnel to become our general counsel to be "extremely odd."

Maybe that person is doing a bunch of due diligence on ONCS' IP to ensure that everything is "in order" before a buyout offer is tendered sometime later in 2015? Who knows.

IF a buyout occurs before any P3 trials have been completed I'd expect it to be for a little less than $1B. Right now I'd say we're worth $200-300M. Still, in any scenario, that's a huge premium from the share price today.

Whatever the case may be, the future is bright for ONCS and cancer patients around the world. At the end of the day, that is what really matters.